Association of Epstein – Barr Virus with malignant transformation of breast

Authors

  • Alaa Mahdy Obaid Khzal B iology Department , college of Science ,University of Kufa,Najaf , Iraq Author
  • Musa Nima Mezher Biology Department , college of Science ,University of Kufa,Najaf , Iraq Author
  • Mohammed Jaber Mhawish Biology Department , college of Science ,University of Kufa,Najaf , Iraq Author

DOI:

https://doi.org/10.61841/6ttv6k40

Keywords:

Epstein- Barr virus, Immunohistochmistry, Breast cancer

Abstract

This study was conducted to identify the Epstein –Barr virus in breast cancer the most common cancer in females for exploring possible viral association with breast malignancies. This project were included 52 formalin fixed paraffin embedded (FFPE) tissue based samples so as called as blocks as (10 benign 32 malignant and 10 healthy breast tissues as control) from females with breast tumors in the central cancer of Al- Sader Teaching Hospital additional to the private laboratory in Al-Najaf city. This study was performed on cases constituting (76.19 %) malignancy (23.81 %) benign breast lesions. The work project in methodology based on immunohistochemistry (IHC) for detecting the Epstein –Barr virus related latent membrane protein -1. These malignant samples were higher rates (37.50%) within the range (45-54) years of the patient`s ages as well as 26/32 (81.25%) positive lymph node involvement and invasive ductal carcinoma rather than invasive lobular type. In the term of viral associated breast cancer, we found a clear significance as P< 0.01 to EBV positivity in malignant breast tissues 11(34.37 %) compared to the benign at which no evidence of association had reported , even we significantly registered as P< 0.01 in the percentages of EBV with many cancer related clinicopathological characteristics such as grade 3 and T2 stage of tumor size as 6(54.55 %) for each of them additional to N3 stage of lymphatic status 4(36.36%) compared to 6 ( 28.57%) , 11( 52.38%) and 7(33.33%) respectively for EBV negativity . In conclusion: EBV was represented a possible etiologic agent or a risk for breast cancer.

Downloads

Download data is not yet available.

References

1. Yahia, ZA.; Adam, AA.; Elgizouli, M.; Hussein, A.; Masri, MA. and Kamal, M. Epstein Barr virus: a prime candidate of breast cancer etiology in Sudanese patients. Infect Agent Cancer. 2014; 9(1): 9.

2. Lafta R. Risk Factors of Breast Cancer among Women (A Sample from Baghdad). Iraqi J. Comm. Med. 2013; (1): 1-6.

3. Alsamarai, AM. and Abdula, SS. Breast cancer frequency rate shift toward younger age in Iraq. Science and Technology. 2015; 5(1): 407–414.

4. Thorley-Lawson, D.A. EBV Persistence--Introducing the Virus through integration with MAPK cascade (RAF-1, MEK1/2, and ERK1/2). Oncogene. 2015; 29: 3100–9.

5. Tsao, SW.; Tsang, CM.; To, KF. and Lo, KW. The role of Epstein-Barr virus in epithelial malignancies. J. Pathol. 2015; 235: 323–333.

6. Sharifpour, C., et al. Frequency of Epstein–Barr Virus DNA in FFPE Tissue of Patients with Ductal Breast Carcinoma. APJCP. 2019; 20(3): 687–692.

7. Fessahaye, G. and Ibrahim, M. Breast Cancer as an Epstein-Barr Virus (EBV)-Associated Malignancy. Braz J Med Biol Res. 2017; 40(8): 1071–1078.

8. Nanbo, A., et al. Roles of Cell Signaling Pathways in Cell-to-Cell Contact-Mediated EBV Transmission. J Virol. 2012; 86(17): 9285–9.

9. Odumade, O.; Hogquist, A. and Balfour, L. Progress and Problems in Understanding and Managing Primary EBV Infections. ASM. 2011; 24(1): 193–209.

10. Glenn, WK.; et al. Epstein-Barr Virus, HPV and Mouse Mammary Tumor Virus as Multiple Viruses in Breast Cancer. PLoS ONE. 2012; 7(11): e48788.

11. Hu, H.; et al. EBV infection of mammary epithelial cells promotes malignant transformation. EBioMedicine. 2016; 9:148–160.

12. Ersing, I.; Bernhardt, K. and Gewurz, BE. NF-κB and IRF7 pathway activation by EBV LMP1. Viruses. 2013; 5(6): 1587–1606.

13. Seavey, MM. and Dobrzanski, P. The many faces of Janus kinase. Biochem Pharmacol. 2012; 83(9):1136–45.

14. Kieser, A. and Sterz, KR. The latent membrane protein 1 (LMP1). Epstein Barr Virus. 2015; 2:119–149.

15. Willems, L. and Gillet, A. APOBEC3 interference during replication of viral genomes. Viruses. 2015; 7(6): 2999–3018.

16. Shi, Y.; et al. Co-infection of EBV and HPV in tumorigenesis. Chin J Cancer. 2016; 35:16.

17. Burns, MB., et al. APOBEC3B is an enzymatic source of mutation in breast cancer. Nature. 2013; 494: 366–370.

18. Roessler, J.; et al. CpG island methylator phenotype in breast cancer and lobular subtype. Epigenomics. 2015; 7(2):187–199.

19. Labrecque, LG.; Barnes, DM.; Fentiman, IS. and Griffin, BE. EBV in epithelial tumors: a breast cancer study. Cancer Res. 1995; 55(1): 39–45.

20. Mezher, MN.; Dakhil, AS. and Abdul_Jawad, DH. Role of EBV in Human Females with Breast Cancer. J Pharm Sci & Res. 2017; 9(7): 1173–1177.

21. Abdulghani Mohamed Alsamarai. Association of HCMV and EBV with Breast Cancer. IJMS. 2018; 1(2):1–8.

22. Aboulkassim, T.; et al. Incidence of EBV in Syrian women with breast cancer. Human Vaccines & Immunotherapeutics. 2015; 11(4): 951–955.

23. Wei, G.; et al. Expression of STAT3 in Breast cancer and its clinical significance. J Cancer Res & Therapy. 2015; 11(5): 56–58.

24. Majid RA., et al. Population study of Kurdish breast cancer: hormone receptor & HER2 status. BMC Women’s Health. 2012; 12:16.

25. Chasib TJ.; Hawaz M.; Jasim NH. Evaluation of estrogen and progesterone receptors in breast cancer. Basrah J Surg. 2013; 19:9–14.

26. Najjar H. and Easson A. Age at diagnosis of breast cancer in Arab nations. Int J Surg. 2010; 8:448–452.

27. Aldiab A., et al. Review on breast cancer in Saudi Arabia. Midd East Sci Res. 2013; 14: 532–543.

28. Morales-Sanchez, A., et al. No association between EBV or MMTV with breast cancer in Mexican women. Sci Rep. 2013; 3:2970.

29. Saeedi, Z.; et al. Relationship between EBV and Breast cancer in Iran. JABR. 2018; 5(3): 943–948.

30. Fadavi P., et al. EBV may not be associated with breast cancer in Iranian patients. Oncol Discov. 2013; 1:3.

31. Huo Q.; Zhang N.; Yang Q. EBV Infection and Sporadic Breast Cancer Risk: A Meta-Analysis. PLoS ONE. 2012; 7(2): e31656.

32. Zekri AN.; et al. EBV and breast cancer: study on Egyptian and Iraqi women. J Egyptian Nat Cancer Institute. 2012; 24:123–131.

33. Hassab El-Naby, N.; et al. EBV infection and invasive ductal carcinoma in Egyptian women. J Egyptian NCI. 2017; 29: 77–82.

34. Joshi, D.; et al. Association of EBV infection with breast cancer in rural Indian women. PLoS ONE. 2009; 4(12): e8180.

Downloads

Published

06.06.2020

Issue

Vol. 24 No. 10 (2020): 24 (10) 2020

Section

Articles

License

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

You are free to:

  1. Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
  2. Adapt — remix, transform, and build upon the material for any purpose, even commercially.
  3. The licensor cannot revoke these freedoms as long as you follow the license terms.

Under the following terms:

  1. Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
  2. No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.

Notices:

You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .

No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.

How to Cite

Alaa Mahdy Obaid Khzal, Mezher, M. N., & Mhawish , M. J. (2020). Association of Epstein – Barr Virus with malignant transformation of breast . International Journal of Psychosocial Rehabilitation, 24(10), 1830-1843. https://doi.org/10.61841/6ttv6k40